ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20859177.
- Also identified by DOI 10.1097/AOG.0b013e3181fae884.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fragile X syndrome is the most common inherited form of mental retardation. The syndrome occurs in approximately 1 in 3,600 males and 1 in 4,000-6,000 females. Approximately 1 in 250 females carry the premutation. DNA-based molecular analysis is the preferred method of diagnosis for fragile X syndrome and its premutations. Prenatal testing for fragile X syndrome should be offered to known carriers of the fragile X premutation or full mutation. Women with a family history of fragile X-related disorders, unexplained mental retardation or developmental delay, autism, or premature ovarian insufficiency are candidates for genetic counseling and fragile X premutation carrier screening.
Medical subject headings
- Fragile X Syndrome
- Genetic Carrier Screening